首页 > 市场调查报告书 > 材料

市场调查报告书

商品编码

1455781

全球油菜籽卵磷脂市场 - 2023-2030

Global Rapeseed Lecithin Market - 2023-2030

出版日期: 2024年03月26日 | 出版商:

DataM Intelligence | 英文 209 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球油菜籽卵磷脂市场达到2.102亿美元，预计2030年将达到3.638亿美元，2023-2030年预测期间CAGR为7.1%。

近年来，消费者对各行业天然、永续和有用成分的需求不断增长，推动了全球油菜籽卵磷脂市场的稳定成长。菜籽卵磷脂源自菜籽油，作为乳化剂、稳定剂和分散剂，为食品、製药、化妆品和工业应用提供了适应性强的选择。

根据 foodInsight 出版物，最近的资料估计，全球 1.1% 至 10.8% 的人口患有食物过敏，食物过敏率似乎正在上升。由于消费者对产品的成分越来越挑剔并且注重健康，油菜籽卵磷脂的非基因改造和无过敏原特性使其成为大豆和向日葵卵磷脂等更传统来源的理想替代品。

非基因改造油菜籽卵磷脂在全球油菜籽卵磷脂市场中占有最大的市场份额。同样，亚太地区在油菜籽卵磷脂市场上占据主导地位，占据最大市场份额，超过 1/3。随着该地区的美容和个人护理行业不断创新和多元化，油菜籽卵磷脂提供了一种理想的成分选择，可以满足监管要求和消费者对功效、安全性和环境责任的期望。

动力学

对非基因改造和无过敏原成分的需求不断增加

消费者越来越关注食品、药品、化妆品和工业产品中使用的成分，从而偏好清洁标籤和不含基因改造生物 (GMO) 和过敏原的产品。油菜籽卵磷脂由于其非基因改造状态和无过敏原特性，成为大豆和向日葵卵磷脂等传统来源的有吸引力的替代品。

根据医疗机构的报告，花生过敏是世界上最常见的食物过敏之一。在西方世界，某些人群的盛行率可能高达每 200 人中就有 1 人患病。在英国，花生过敏者占总人口的 0.4% 至 0.6%。研究表明，花生过敏约占儿童所有食物过敏的 28%，并且约一半的病例是在孩子一岁生日之前发生的。 15 岁后很少出现过敏（仅 7% 的病例）。

随着世界各地的监管机构收紧对基因改造成分和过敏原的法规和标籤要求，製造商面临着用非基因改造和无过敏原替代品重新配製其产品的压力。油菜籽卵磷脂满足这些要求，为製造商提供了符合消费者偏好和监管要求的多功能功能性成分。这导致各行业对油菜籽卵磷脂的需求激增。

人们越来越意识到油菜籽卵磷脂的健康益处

根据美国国立卫生研究院的资料，到2023年，甚至仍有75%的患者超过低密度脂蛋白胆固醇（LDL-C）目标，而高胆固醇血症是最常见、监测最差的心血管危险因子。世界心臟联盟2023 年报告指出，全球有超过5 亿人继续受到心血管疾病的影响，2021 年心血管疾病死亡人数为2,050 万人，接近全球死亡人数的三分之一，并且估计的总体死亡人数增加。1.21 亿人因心血管疾病死亡。

油菜籽卵磷脂对心血管健康的有益作用是其主要的健康优势之一。胆固醇和磷脂酰丝胺酸属于磷脂，存在于油菜籽卵磷脂中，与血管功能、胆固醇水平和脂质代谢的改善有关。对于关心心臟健康的人来说，油菜籽卵磷脂是理想的成分，因为研究表明，经常摄取可能有助于降低心臟病的风险并增强心臟健康。

此外，油菜籽卵磷脂对维持认知健康和大脑功能的贡献已得到公认。磷脂酰胆碱是油菜籽卵磷脂的主要成分，是乙酰胆碱的前体，乙酰胆碱是对记忆、学习和认知过程至关重要的神经传导物质。研究表明，食用富含磷脂酰胆碱的食物，包括油菜籽卵磷脂，可以改善认知功能并降低与年龄相关的认知能力下降的发生率。

油菜籽供应有限且波动

供应限制加剧和油菜籽供应有限是全球油菜籽卵磷脂市场的主要障碍。油菜籽卵磷脂的主要来源是油菜籽，其可用性受到多种变数的影响，例如全球供需动态、天气模式和耕作技术。干旱、洪水或虫害等不利的气候条件可能会导致油菜籽产量波动，从而降低产量并减少可用于提取卵磷脂的油菜籽数量。

此外，油菜籽是一种商品作物，其种植有多种用途，例如生产石油、动物饲料和生物燃料。其他企业之间对油菜籽的竞争可能会进一步限制其卵磷脂提取的可及性。例如，石油价格的变化可能会影响农民的种植选择，并导致分配给油籽提取的油菜籽面积相对于其他用途变化。此外，用于生产卵磷脂的油菜籽的可用性可能会受到生物燃料生产成长的影响。

The growing consumer demand for natural, sustainable, and useful ingredients across a range of industries has propelled the steady rise of the global rapeseed lecithin market in recent years. Rapeseed lecithin, which is derived from rapeseed oil, provides an adaptable option for use in food, pharmaceutical, cosmetic, and industrial applications as an emulsifier, stabilizer, and dispersion agent.

According to foodInsight publications, recent data estimate that between 1.1 and 10.8% of the global population has a food allergy, and the rates of food allergies appear to be increasing. Since customers are growing more picky about the contents of their products and are health-conscious, rapeseed lecithin's non-GMO and allergen-free status has made it a desirable substitute for more conventional sources like soy and sunflower lecithin.

The non-GMO rapeseed lecithin accounts largest market share in the global rapeseed lecithin market. Similarly, Asia-Pacific dominates the rapeseed lecithin market, capturing the largest market share of over 1/3rd. As the region's beauty and personal care industry continues to innovate and diversify, rapeseed lecithin offers a desirable ingredient option that meets regulatory requirements and consumer expectations for efficacy, safety, and environmental responsibility.

Dynamics

Increasing Demand for Non-GMO and Allergen-Free Ingredients

Consumers are becoming more conscious of the ingredients used in their food, pharmaceuticals, cosmetics, and industrial products, leading to a preference for cleaner labels and products free from genetically modified organisms (GMOs) and allergens. Rapeseed lecithin serves as an attractive alternative to traditional sources such as soy and sunflower lecithin due to its non-GMO status and allergen-free profile.

According to a medical agency report, peanut allergy is one of the most common food allergies found worldwide. In the Western world, the prevalence can be as high as 1 in 200 individuals in some populations. In the United Kingdom, peanut allergy is present in between 0.4 and 0.6% of the whole population. Studies show that peanut allergy forms around 28% of all food allergies in children and develops before the child reaches their first birthday in about half of cases. The allergy rarely develops after 15 years of age (in only 7% of cases).

As regulatory agencies worldwide tighten regulations and labeling requirements for GMO ingredients and allergens, manufacturers are under pressure to reformulate their products with non-GMO and allergen-free alternatives. Rapeseed lecithin meets these requirements, offering manufacturers a versatile and functional ingredient that aligns with consumer preferences and regulatory mandates. This has led to a surge in demand for rapeseed lecithin across various industries.

Growing Awareness of Health Benefits Associated with Rapeseed Lecithin

According to the National Institute of Health data, In 2023 there are still even 75% of patients over the target of low-density lipoprotein cholesterol (LDL-C), and hypercholesterolemia is the most common and the worst monitored cardiovascular risk factor. The World Heart Federation report of 2023 states that more than half a billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021 - close to a third of all deaths globally and an overall increase in the estimated 121 million CVD deaths.

The beneficial effects of rapeseed lecithin on cardiovascular health are among its main health advantages. Cholesterol and phosphatidylserine, which are phospholipids and can be found in rapeseed lecithin, have been associated with improvements in vascular function, cholesterol levels, and lipid metabolism. Rapeseed lecithin is a desirable ingredient for people who are concerned about their heart health because studies indicate that frequent ingestion may help lower the risk of heart disease and enhance heart health.

Moreover, rapeseed lecithin's contribution to maintaining cognitive health and brain function is acknowledged. A primary constituent of rapeseed lecithin, phosphatidylcholine is a precursor to acetylcholine, a neurotransmitter crucial for memory, learning, and cognitive processes. Studies suggest that eating foods high in phosphatidylcholine, including rapeseed lecithin, may improve cognitive function and lower the incidence of age-related cognitive decline.

Limited Availability and Fluctuations in Rapeseed Supply

Raising supply constraints and limited availability of rapeseed are major obstacles to the global market for rapeseed lecithin. The main source of rapeseed lecithin is rapeseed, and its availability is influenced by several variables, such as global supply and demand dynamics, weather patterns, and farming techniques. Unfavorable climatic conditions like droughts, floods, or pest infestations can cause fluctuations in the production of rapeseed, which can lower yields and decrease the amount of rapeseed that is available for lecithin extraction.

Furthermore, rapeseed is a commodity crop that is grown for a variety of uses, such as the production of oil, animal feed, and biofuel. The competition between other businesses for rapeseed may further restrict its accessibility for lecithin extraction. Changes in oil prices, for instance, could affect farmers' planting choices and cause rapeseed acreage allocated to oilseed extraction to change relative to other purposes. Furthermore, the availability of rapeseed for the production of lecithin may be impacted by the growth of biofuel production.

Segment Analysis

The global rapeseed lecithin market is segmented based on origin, form, application, distribution channel and region.

The Surging Demand for Non-GMO Rapeseed Lecithin in the Global Market

Growing consumer awareness of and preference for products with clean labeling is one of the main factors driving the demand for non-GMO rapeseed lecithin. Natural and minimally processed components are in more demand as people grow more health-conscious and picky about the ingredients in their diets, pharmaceuticals, beauty products, and commercial products. This need is met by non-GMO rapeseed lecithin, which provides a non-genetically modified substitute for conventional lecithin sources like soybeans and sunflower seeds.

The increasing use of non-GMO rapeseed lecithin in a variety of product categories can be attributed to this since it is in line with customer demands for natural ingredients, transparency, and sustainability. According to Austrade Inc., research data, interest in non-GMO, allergen-free rapeseed lecithin has grown tremendously over the past decade due to global GMO and allergenic issues in soybeans.

According to a nutraceutical business review published in 2023, economic considerations encourage a switch to rapeseed lecithin by customers. For more than 30 years, rapeseed lecithin has been lower in price than lecithin from other non-GM botanical sources. As a natural product, mostly regionally grown and produced with short transport distances between growers and final customers, rapeseed lecithin also has an attractively low environmental impact.

Geographical Penetration

Rising Tide: Unveiling Asia-Pacific's Appetite for Rapeseed Lecithin Innovation

The expanding food and beverage sector is one of the main factors driving the demand for rapeseed lecithin in the Asia-Pacific region. Demand for processed foods, confectionery, baked goods, and convenience products is rising throughout the Asia-Pacific region as a result of rapid urbanization, changing lifestyles, and rising disposable incomes. In these products, rapeseed lecithin improves texture, appearance, and shelf life by acting as a flexible emulsifier and dispersing agent.

Moreover, according to the National Institutes of Health data, China is the largest producer of rapeseed in the Asia-Pacific region, producing more than 14.7 million tons in 2021. This is more than three times the amount produced by India, the second-largest producer, and 59% of the total volume produced in the region. Japan is the third-largest producer, accounting for 10% of the total volume.

In addition, the Asia-Pacific region's pharmaceutical and nutraceutical sectors support the need for rapeseed lecithin. The market for functional foods, pharmaceutical formulations supplemented with rapeseed lecithin, and dietary supplements is expanding due to an aging population and greater consciousness of health and wellness. The possible health benefits of phospholipids and essential fatty acids found in rapeseed lecithin include support for the cardiovascular system, improvement of cognitive function, and promotion of liver health.

COVID-19 Impact Analysis

The COVID-19 pandemic had a major effect on the global market for rapeseed lecithin, upsetting supply networks, cutting consumer expenditure, and changing consumption habits. Logistical difficulties resulting from movement restrictions and lockdown measures affected the availability and transportation of raw materials needed to produce lecithin.

Furthermore, the pandemic-induced economic slump resulted in decreased demand from sectors including food, medicine, and cosmetics, which affected the total amount of rapeseed lecithin consumed. But despite the crisis, people's concern for their health and well-being grew, which fueled the market for natural and useful components like rapeseed lecithin, especially in industries that valued clean labels and non-GMO products.

Russia-Ukraine War Impact Analysis

The geopolitical instability and conflicts brought about by the Russia-Ukraine war have the potential to upset the global market for rapeseed lecithin. As Ukraine is one of the world's top producers of rapeseed, any interruptions to its ability to manufacture or export could have an effect on the availability of rapeseed lecithin worldwide. Furthermore, Russia is a big player in the rapeseed market, so any escalation of the conflict would cause disruptions to trade and volatility in prices.

Furthermore, changes in sourcing tactics and pricing trends may result from the war's impact on the market dynamics in nearby nations and regions. In order to reduce the risks associated with the Russia-Ukraine conflict, companies in the rapeseed lecithin industry may need to diversify their supply chains and keep an open mind on geopolitical developments.

By Origin

Organic
Conventional
Non-GMO

By Form

Powder
Liquid
Granular
Others

By Application

Food and Beverage
Pharmaceuticals
Cosmetics & Personal Care
Industrial
Others

By Distribution Channel

Supermarkets/Hypermarkets
Online Retail
Specialty Stores
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In November 2023, Sternchemie GmbH & Co. KG expanded its business by focusing on quality and functionality. With its current quality standards, rapeseed has overcome the critical image it once had. By modifying seed and improvement of production and processing steps, rapeseed lecithin has reached the same level as lecithin from other botanical sources.
In December 2021, Sternchemie GmbH & Co. KG introduced new additions to its lecithin product portfolio - the SternInstant and SternPhil series. These are sprayable lecithin blends that are made with soy, rapeseed or sunflower lecithin that can be utilised by manufacters of instant products.
In February 2021, Sternchemie GmbH & Co. KG expanded its portfolio by focusing more on rapeseed, whose functionality is very similar to soy lecithin in many applications. The existing rapeseed portfolio is accordingly being expanded with new solutions that offer full-function alternatives to soy lecithin, especially in situations where flavor and oxidation problems can arise, such as in chocolate or instant products.

Competitive Landscape

The major global players in the market include Cargill, Incorporated, ADM (Archer Daniels Midland Company), Bunge Lecithins, DuPont Nutrition & Biosciences, Lipoid GmbH, American Lecithin Company, Thew Arnott & Co Ltd, Lasenor Emul, Lecico GmbH and Sternchemie GmbH & Co. KG.

Why Purchase the Report?

To visualize the global rapeseed lecithin market segmentation based on origin, form, application, distribution channel, and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of rapeseed lecithin market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.

The global rapeseed lecithin market report would provide approximately 70 tables, 66 figures, and 209 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1.Methodology and Scope

1.1.Research Methodology
1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

3.1.Snippet By Origin
3.2.Snippet by Form
3.3.Snippet by Application
3.4.Snippet by Distribution Channel
3.5.Snippet by Region

4.Dynamics

4.1.Impacting Factors
- 4.1.1.Drivers
  - 4.1.1.1.Increasing Demand for Non-GMO and Allergen-Free Ingredients
  - 4.1.1.2.Growing Awareness of Health Benefits Associated with Rapeseed Lecithin
- 4.1.2.Restraints
  - 4.1.2.1.Limited Availability and Fluctuations in Rapeseed Supply
- 4.1.3.Opportunity
- 4.1.4.Impact Analysis

5.Industry Analysis

5.1.Porter's Five Force Analysis
5.2.Supply Chain Analysis
5.3.Pricing Analysis
5.4.Regulatory Analysis
5.5.Russia-Ukraine War Impact Analysis
5.6.DMI Opinion

6.COVID-19 Analysis

6.1.Analysis of COVID-19
- 6.1.1.Scenario Before COVID
- 6.1.2.Scenario During COVID
- 6.1.3.Scenario Post COVID
6.2.Pricing Dynamics Amid COVID-19
6.3.Demand-Supply Spectrum
6.4.Government Initiatives Related to the Market During Pandemic
6.5.Manufacturers Strategic Initiatives
6.6.Conclusion

7.By Origin

7.1.Introduction
- 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 7.1.2.Market Attractiveness Index, By Origin
7.2.Organic*
- 7.2.1.Introduction
- 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3.Conventional
7.4.Non-GMO

8.By Form

8.1.Introduction
- 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2.Market Attractiveness Index, By Form
8.2.Powder*
- 8.2.1.Introduction
- 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3.Liquid
8.4.Granular
8.5.Others

9.By Application

9.1.Introduction
- 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2.Market Attractiveness Index, By Application
9.2.Food & Beverage*
- 9.2.1.Introduction
- 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3.Pharmaceuticals
9.4.Cosmetics & Personal Care
9.5.Industrial
9.6.Others

10.By Distribution Channel

10.1.Introduction
- 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.1.2.Market Attractiveness Index, By Distribution Channel
10.2.Supermarkets/Hypermarkets*
- 10.2.1.Introduction
- 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3.Online Retail
10.4.Specialty Stores
10.5.Others

11.By Region

11.1.Introduction
- 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2.Market Attractiveness Index, By Region
11.2.North America
- 11.2.1.Introduction
- 11.2.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.2.6.1.U.S.
- 11.2.6.2.Canada
- 11.2.6.3.Mexico

11.3.Europe
- 11.3.1.Introduction
- 11.3.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.3.6.1.Germany
- 11.3.6.2.UK
- 11.3.6.3.France
- 11.3.6.4.Italy
- 11.3.6.5.Spain
- 11.3.6.6.Rest of Europe

11.4.South America
- 11.4.1.Introduction
- 11.4.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin

11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 11.4.6.1.Brazil
- 11.4.6.2.Argentina
- 11.4.6.3.Rest of South America

11.5.Asia-Pacific
- 11.5.1.Introduction
- 11.5.2.Key Region-Specific Dynamics
- 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1.China
  - 11.5.7.2.India
  - 11.5.7.3.Japan
  - 11.5.7.4.Australia
  - 11.5.7.5.Rest of Asia-Pacific
11.6.Middle East and Africa
- 11.6.1.Introduction
- 11.6.2.Key Region-Specific Dynamics
- 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Origin
- 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12.Competitive Landscape

12.1.Competitive Scenario
12.2.Market Positioning/Share Analysis
12.3.Mergers and Acquisitions Analysis

13.Company Profiles

13.1.Cargill, Incorporated*
- 13.1.1.Company Overview
- 13.1.2.Product Portfolio and Description
- 13.1.3.Financial Overview
- 13.1.4.Key Developments
13.2.ADM (Archer Daniels Midland Company)
13.3.Bunge Lecithins
13.4.DUPONT DE NEMOURS, INC.
13.5.Lipoid GmbH
13.6.American Lecithin Company
13.7.Thew Arnott & Co Ltd
13.8.Lasenor Emul
13.9.Lecico GmbH
13.10.Sternchemie GmbH & Co. KG

LIST NOT EXHAUSTIVE